Business Wire
-
Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler To Advance PCR Flexibility Productivity
4/16/2026
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Applied Biosystems PowerFlex Thermal Cycler, a next-generation polymerase chain reaction (PCR) instrument designed to help deliver enhanced flexibility, precise thermal performance and improved productivity for modern molecular biology laboratories.
-
Invivoscribe Announces The PrepQuant™ System, An Integrated Sample Preparation Platform That Standardizes And Streamlines Pre-Analytical Workflows
4/15/2026
Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the PrepQuant System, a novel sample preparation platform that integrates nucleic acid extraction, concentration, and quantification with a single automated instrument.
-
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
4/14/2026
QIAGEN N.V. today announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel.
-
Rune Labs Launches Parkinson's AI Companion Trained On The World's Largest Parkinson's Dataset
4/8/2026
Today, Rune Labs announced the launch of a personalized AI companion to provide always-on support for people with Parkinson’s disease. Powered by Anthropic's Claude and built on Rune Labs' proprietary longitudinal dataset, comprising millions of hours of wearable data and FDA-cleared symptom algorithms, StrivePD Guardian continuously analyzes patients' real-time data to deliver timely, context-aware guidance on symptoms, medications, daily experiences, and care goals.
-
Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM
3/31/2026
Thermo Fisher Scientific, the world leader in serving science, today introduces a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural biology with greater clarity — now accessible in more lab environments than ever before.
-
Ataraxis AI Launches Ataraxis Breast CTX, The First Predictive AI Test Estimating Individualized Chemotherapy Benefit In Breast Cancer
3/30/2026
Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis Breast CTX, a new predictive capability within its Ataraxis Breast platform, designed to help estimate individualized chemotherapy benefit in breast cancer patients.
-
StarLIMS To Acquire The MODA Platform From Lonza, Expanding Deeper Into Manufacturing Operations & Quality Control
3/25/2026
StarLIMS has agreed to acquire the MODA Platform, a trusted solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions.
-
CorePlus And Ibex Expand Partnership With Clinical Deployment Of AI-Powered Diagnostics For TURP
3/25/2026
CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a high-complexity CLIA-certified laboratory and global leader in digital transformation, and Ibex Medical Analytics (Ibex), a pioneer in AI-powered cancer diagnostics, today announced the first clinical deployment of Ibex Prostate for Transurethral Resection of the Prostate (TURP), an AI solution for rapid, high-volume diagnostic support.
-
Countable Labs Brings Innovative, Single-Molecule, Counting-Based PCR To European Markets With CE Mark Clearance
3/25/2026
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, achieved CE marking for its Countable 4 Platform, a single-molecule PCR instrument for molecular quantification featuring Countable PCR technology.
-
Integrated DNA Technologies Expands Into Clinical Diagnostics With First In Vitro Diagnostic
3/23/2026
Global genomics leader Integrated DNA Technologies (IDT) today announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx in vitro diagnostic (IVD) offerings.